As a result, α-KG is increasingly converted into D-2 hydroxyglutarate (D2HG), an oncometabolite that promotes tumor growth and metastasis through various mechanisms, including DNA methylation and VEGFR activation [217]. The gene discussed is KDR; the disease is neoplasm.